InvestorsHub Logo

DewDiligence

07/26/17 1:01 PM

#212664 RE: DewDiligence #212663

EGRX resumes trading down 21% (eom).

Bickema

07/26/17 2:45 PM

#212668 RE: DewDiligence #212663

Dew you called this, I remember you were concerned with the lack of a US based study

But all told I figured this would be one of the drugs that would benefit from the new FDA protocols, Ryanodex has proven to be a very safe drug to a life threatening condition with no approved drugs.

Now the question how Eagle is going to proceed and whether or not they can get together a new full enrolled trial by the end of summer. albeit a much larger trial here in the states.

Should Eagle been working on a US trial anyway?